Skip to main content

Table 2 Overall survival outcome data

From: Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies

From the time of Median OS (range), months
initial brain metastasis (n = 79) 12.8 (1.1–71.9)
initial melanoma diagnosis (n = 79) 60.5 (5.5–367.1)
the first craniotomy (n = 34) 17.3 (2.4–60.7)
the first stereotactic radiosurgery (n = 54) 15.4 (1.2–71.8)
the first whole brain radiation therapy (n = 16) 6.8 (2.2–12.5)
  1. OS, overall survival